Friday 23rd September 2016 |
|
|---|---|
| SESSION V – IMMUNOGENETICS IN THE NGS ERA | |
| Chair: Ton Langerak (NL) | |
| 09:00 |
Anna Vardi (GR) - Technical considerations for NGS analysis of immunoglobulin gene repertoires |
| 09:20 | Anastasia Hadzidimitriou (GR) - IMGT/High V-QUEST tool |
| 09:30 | Nikos Darzentas (CZ) - Bioinformatics: State-of-art tools for NGS immunogenetics |
| 10:00 | Kostas Stamatopoulos (GR) - Challenges with immunogenetics in the NGS era |
| 10:30 | Round Table Discussion/Debate: Sanger versus NGS for IG gene analysis within clinical routine: what is feasible? Panel: Fred Davi (FR), Kostas Stamatopoulos (GR), Ton Langerak (NL) |
| 11:15 | Coffee break |
| SESSION VI – IMMUNOGENETICS AND DISEASE FOLLOW-UP: TRACKING MRD | |
| Chair: Paolo Ghia (IT) | |
| 11:45 |
Christiane Pott (DE) - New developments in MRD monitoring via NGS in mature B cell malignancies |
| 12:15 | Andy Rawstron (GB) - Flow cytometric vs PCR MRD for CLL |
| 12:45 | Andy Rawstron (GB) - Guidelines for interpreting MRD flow data (hands-on computer session) |
| 13:15 |
Round Table Discussion/Debate: MRD detection in CLL and B cell lymphomas: what does the future hold? Panel: Andy Rawstron (GB), Paolo Ghia (IT), Christiane Pott (DE) |
| 13:45 | Anastasia Hadzidimitriou (GR) - Concluding remarks |
| 14:00 | Lunch |
| 15:30 | Meeting concludes |